Maks_Lab
Indivior (OTCPK:INVVY) (OTCPK:IZQVF) is acquiring opioid overdose therapy maker Opiant Pharmaceuticals (NASDAQ:OPNT) for ~$145M.
North Chesterfield, Va.-based Indivior will acquire all outstanding shares of Opiant for an upfront $20 per share in cash, plus up to $8 per share in contingent value rights (CVRs) that